The results indicated that SAP/SH2D1A mRNA levels are significantly lower in RA patients than in controls, suggesting that the reduced expression of the gene may have some role in the impaired EBV-specific T-cell responses in RA. The gene discussed is SH2D1A; the disease is rheumatoid arthritis.